(Q44179168)

English

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

scientific article published in October 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

chronic obstructive pulmonary disease

0 references

fluticasone propionate

1 reference

based on heuristic

inferred from title

author name string

Donald A Mahler

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Patrick Wire

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Donald Horstman

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Chai-Ni Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Julie Yates

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Tracy Fischer

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Tushar Shah

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

166

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1084-1091

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Pulmonary rehabilitation in patients with COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Inhaled corticosteroids in stable COPD patients: do they have effects on cells and molecular mediators of airway inflammation?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

A measure of quality of life for clinical trials in chronic lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Optimizing bronchodilator therapy for copd

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Efficacy of salmeterol xinafoate in the treatment of COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Additive effects of salmeterol and fluticasone or theophylline in COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Salmeterol reduces dyspnea and improves lung function in patients with COPD

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Changes in dyspnea, health status, and lung function in chronic airway disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Quality of life changes in COPD patients treated with salmeterol

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112055

21 January 2018

Identifiers

10.1164/RCCM.2112055

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44179168&oldid=2108306810"